Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.

Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.

Item
http://www.wikidata.org/entity/Q37345488
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis.Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Efficacy and safety of tofacitinib for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.Tofacitinib: A New Oral Therapy for Psoriasis.Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups.Autoimmunity and autoimmune co-morbidities in psoriasis.Advances in treating psoriasis in the elderly with small molecule inhibitors.Tofacitinib in psoriatic arthritis.
P2860

Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.

Item
http://www.wikidata.org/entity/Q37345488
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral tofacitinib efficacy, saf ...... , double-blind, phase 3 study.
@en
Oral tofacitinib efficacy, saf ...... , double-blind, phase 3 study.
@nl
type
label
Oral tofacitinib efficacy, saf ...... , double-blind, phase 3 study.
@en
Oral tofacitinib efficacy, saf ...... , double-blind, phase 3 study.
@nl
prefLabel
Oral tofacitinib efficacy, saf ...... , double-blind, phase 3 study.
@en
Oral tofacitinib efficacy, saf ...... , double-blind, phase 3 study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Oral tofacitinib efficacy, saf ...... , double-blind, phase 3 study.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932